Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P95
Near historical high
vs 2Y Ago
4.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 44.92% |
| Q3 2025 | -30.09% |
| Q2 2025 | 34.91% |
| Q1 2025 | -24.61% |
| Q4 2024 | 1.81% |
| Q3 2024 | -13.28% |
| Q2 2024 | -19.25% |
| Q1 2024 | -8.42% |
| Q4 2023 | 10.28% |
| Q3 2023 | -11.57% |
| Q2 2023 | 17.63% |
| Q1 2023 | 7.78% |
| Q4 2022 | -25.43% |
| Q3 2022 | -11.81% |
| Q2 2022 | 34.68% |
| Q1 2022 | -38.69% |
| Q4 2021 | -35.22% |
| Q3 2021 | -27.06% |
| Q2 2021 | 26.90% |
| Q1 2021 | -14.83% |
| Q4 2020 | -45.35% |
| Q3 2020 | 17.85% |
| Q2 2020 | -27.18% |
| Q1 2020 | -2.96% |
| Q4 2019 | -2.80% |
| Q3 2019 | 7.42% |
| Q2 2019 | -2.47% |
| Q1 2019 | 7.00% |
| Q4 2018 | -3.83% |
| Q3 2018 | -7.04% |
| Q2 2018 | -13.81% |
| Q1 2018 | 14.27% |
| Q4 2017 | 49.48% |
| Q3 2017 | -43.44% |
| Q2 2017 | 47.51% |
| Q1 2017 | 2.74% |
| Q4 2016 | -27.88% |
| Q3 2016 | 12.83% |
| Q2 2016 | -16.80% |
| Q1 2016 | -1.57% |